Brian McNamee will step down as CEO of blood plasma company CSL
at the end of June 2013, after 23 years in the job. CSL
, which began life as the Commonwealth Serums Laboratories in 1916, was only worth $A23 million when McNamee became CEO, but it is now ...
[Published Individual.com - Jun 16 2013]